Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

Company Overview - ALX Oncology Holdings Inc. (ALXO) is part of the Medical sector, which includes 928 individual stocks and holds a Zacks Sector Rank of 10 [2] - ALX Oncology is currently rated with a Zacks Rank of 2 (Buy), indicating a positive earnings outlook [3] Performance Metrics - Over the past three months, the Zacks Consensus Estimate for ALXO's full-year earnings has increased by 16.9%, reflecting improved analyst sentiment [4] - ALXO has returned approximately 81.4% year-to-date, significantly outperforming the average gain of 5.3% for Medical stocks [4] - In the Medical - Biomedical and Genetics industry, which includes 449 companies, ALXO is performing better than the average industry gain of 23.6% this year [6] Comparative Analysis - Another Medical stock, Amneal Pharmaceuticals (AMRX), has returned 15.2% year-to-date and has a Zacks Rank of 2 (Buy) [5] - Amneal Pharmaceuticals belongs to the Medical - Drugs industry, which has a lower year-to-date gain of +2.7% and is ranked 146 [7]